{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:43:54Z","timestamp":1794944634837,"version":"4.9.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI124377, AI126603, AI128751, AI129797, AI164556"],"award-info":[{"award-number":["AI124377, AI126603, AI128751, AI129797, AI164556"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["OD024917"],"award-info":[{"award-number":["OD024917"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012802","name":"Ragon Institute of MGH, MIT and Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The latent viral reservoir is the critical barrier for developing an HIV-1 cure. Previous studies have shown that therapeutic vaccination or broadly neutralizing antibody (bNAb) administration, together with a Toll-like receptor 7 (TLR7) agonist, enhanced virologic control or delayed viral rebound, respectively, following discontinuation of antiretroviral therapy (ART) in SIV- or SHIV-infected rhesus macaques. Here we show that the combination of active and passive immunization with vesatolimod may lead to higher rates of post-ART virologic control compared to either approach alone. Therapeutic Ad26\/MVA vaccination and PGT121 administration together with TLR7 stimulation with vesatolimod resulted in 70% post-ART virologic control in SHIV-SF162P3-infected rhesus macaques. These data suggest the potential of combining active and passive immunization targeting different immunologic mechanisms as an HIV-1 cure strategy.<\/jats:p>","DOI":"10.1038\/s41467-022-31196-5","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T03:03:03Z","timestamp":1655348583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques"],"prefix":"10.1038","volume":"13","author":[{"given":"Victoria E. K.","family":"Walker-Sperling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-7326","authenticated-orcid":false,"given":"Noe B.","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7821-5552","authenticated-orcid":false,"given":"Abishek","family":"Chandrashekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica N.","family":"Borducchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Nkolola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7852-0135","authenticated-orcid":false,"given":"Mark","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Murry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romas","family":"Geleziunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-9649","authenticated-orcid":false,"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5882-5548","authenticated-orcid":false,"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Pau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9821-1492","authenticated-orcid":false,"given":"Frank","family":"Wegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8563-2266","authenticated-orcid":false,"given":"Hanneke","family":"Schuitemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Fray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithra R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet D.","family":"Siliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Siliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5127-4659","authenticated-orcid":false,"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"31196_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano, J. D. et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9, 727\u2013728 (2003).","journal-title":"Nat. Med."},{"key":"31196_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","volume":"27","author":"LB Cohn","year":"2020","unstructured":"Cohn, L. B., Chomont, N. & Deeks, S. G. The biology of the HIV-1 latent reservoir and implications for cure strategies. Cell Host Microbe 27, 519\u2013530 (2020).","journal-title":"Cell Host Microbe"},{"key":"31196_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","volume":"563","author":"EN Borducchi","year":"2018","unstructured":"Borducchi, E. N. et al. Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys. Nature 563, 360\u2013364 (2018).","journal-title":"Nature"},{"key":"31196_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nature20583","volume":"540","author":"EN Borducchi","year":"2016","unstructured":"Borducchi, E. N. et al. Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature 540, 284\u2013287 (2016).","journal-title":"Nature"},{"key":"31196_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41591-020-0774-y","volume":"26","author":"DJ Colby","year":"2020","unstructured":"Colby, D. J. et al. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption. Nat. Med. 26, 498\u2013501 (2020).","journal-title":"Nat. Med."},{"key":"31196_CR6","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1016\/S2352-3018(20)30001-1","volume":"7","author":"KE Stephenson","year":"2020","unstructured":"Stephenson, K. E. et al. Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010\/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22). Lancet HIV 7, e410\u2013e421 (2020).","journal-title":"Lancet HIV"},{"key":"31196_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.chom.2019.06.005","volume":"26","author":"AM Bender","year":"2019","unstructured":"Bender, A. M. et al. The landscape of persistent viral genomes in ART-treated SIV, SHIV, and HIV-2 infections. Cell Host Microbe 26, 73\u201385 e74 (2019).","journal-title":"Cell Host Microbe"},{"key":"31196_CR8","doi-asserted-by":"publisher","unstructured":"Tartaglia, L. J. et al. Differential outcomes following optimization of simian-human immunodeficiency viruses from clades AE, B, and C. J. Virol. 94, https:\/\/doi.org\/10.1128\/JVI.01860-19 (2020).","DOI":"10.1128\/JVI.01860-19"},{"key":"31196_CR9","doi-asserted-by":"publisher","unstructured":"Julg, B. et al. Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Sci. Transl. Med. 9, https:\/\/doi.org\/10.1126\/scitranslmed.aao4235 (2017).","DOI":"10.1126\/scitranslmed.aao4235"},{"key":"31196_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature12744","volume":"503","author":"DH Barouch","year":"2013","unstructured":"Barouch, D. H. et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503, 224\u2013228 (2013).","journal-title":"Nature"},{"key":"31196_CR11","doi-asserted-by":"publisher","first-page":"e1009339","DOI":"10.1371\/journal.ppat.1009339","volume":"17","author":"DC Hsu","year":"2021","unstructured":"Hsu, D. C. et al. TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption. PLoS Pathog. 17, e1009339 (2021).","journal-title":"PLoS Pathog."},{"key":"31196_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-020-1951-3","volume":"578","author":"CC Nixon","year":"2020","unstructured":"Nixon, C. C. et al. Systemic HIV and SIV latency reversal via non-canonical NF-kappaB signalling in vivo. Nature 578, 160\u2013165 (2020).","journal-title":"Nature"},{"key":"31196_CR13","doi-asserted-by":"publisher","unstructured":"Dashti, A. et al. SMAC mimetic plus triple-combination bispecific HIVxCD3 retargeting molecules in SHIV.C.CH505-infected, antiretroviral therapy-suppressed rhesus macaques. J. Virol. 94, https:\/\/doi.org\/10.1128\/JVI.00793-20 (2020).","DOI":"10.1128\/JVI.00793-20"},{"key":"31196_CR14","doi-asserted-by":"publisher","unstructured":"Mavigner, M. et al. CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01429-20 (2021).","DOI":"10.1128\/JVI.01429-20"},{"key":"31196_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature21435","volume":"543","author":"Y Nishimura","year":"2017","unstructured":"Nishimura, Y. et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature 543, 559\u2013563 (2017).","journal-title":"Nature"},{"key":"31196_CR16","doi-asserted-by":"publisher","unstructured":"Nishimura, Y. et al. Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia. J. Exp. Med. 218, https:\/\/doi.org\/10.1084\/jem.20201214 (2021).","DOI":"10.1084\/jem.20201214"},{"key":"31196_CR17","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.1073\/pnas.92.16.7490","volume":"92","author":"PA Luciw","year":"1995","unstructured":"Luciw, P. A. et al. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian\/human immunodeficiency viruses (SHIV). Proc. Natl Acad. Sci. USA 92, 7490\u20137494 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31196_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature13594","volume":"512","author":"JB Whitney","year":"2014","unstructured":"Whitney, J. B. et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512, 74\u201377 (2014).","journal-title":"Nature"},{"key":"31196_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21724-0","volume":"12","author":"AM Cadena","year":"2021","unstructured":"Cadena, A. M. et al. Persistence of viral RNA in lymph nodes in ART-suppressed SIV\/SHIV-infected rhesus macaques. Nat. Commun. 12, 1474 (2021).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31196-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31196-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31196-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:49:25Z","timestamp":1669294165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31196-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31196"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31196-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jeff Murray, Yunling Yang, and Romas Geleziunas are employees of Gilead Sciences. Maria G. Pau, Frank Wegmann, and Hanneke Schuitemaker are employees of Janssen Vaccines & Prevention. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3463"}}